Cite Filings / AGIO / 0000902219-18-000060
Feed Companies Filings Check
Sign in
SC 13G/A

Amended Statement of Ownership

AGIOS PHARMACEUTICALS, INC. · Filed 2018-02-08 · Acc 0000902219-18-000060

Documents 1

  • SC 13G/A Amended Statement of Ownership , SEC13G_Filing.htm

Around this filing

  • 2018-02-13 SC 13G/A Amended Statement of Ownership
  • 2018-02-08 SC 13G/A Amended Statement of Ownership
  • 2018-02-08 SC 13G/A Amended Statement of Ownership
  • 2018-02-07 4 Chief Scientific Officer sold 3,000 shares at an average $76.04 ($228,128)
  • 2018-02-05 4 Chief Medical Officer sold 2,000 shares at an average $78.75 ($157,500)
  • 2018-02-05 4 Chief Executive Officer sold 13,000 shares at an average $78.75 ($1,023,756)
  • 2018-02-02 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · D. E. Shaw & Co., L.P. 6.5%
  2. 2026-11-16 SCHEDULE 13G/A · Lynx1 Capital Management LP 0.8%
  3. 2026-11-13 SCHEDULE 13G · Morgan Stanley 5.7%
Loading SEC13G_Filing.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…